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 In tissue engineering (TE) and regenerative medicine, directing 
or modulating cell behavior is known to be vital for the 
development of constructs to replace lost or damaged tissue. [ 1 ] 
In this study, we introduce a material-based bottom-up approach 
which allows to build up millimeter-sized geometrically shaped 
viable tissue constructs. With this new biofabrication platform, 
we show that it is possible to infl uence cell-material interac-
tions and improve the distribution of viable cells throughout 
engineered tissues. By tailoring the physical and chemical prop-
erties of cell-adherent micro-objects functioning as scaffolding 
elements, the compaction and morphology of the formed tissue 
constructs can be modulated. 
 Conventional TE approaches are based on combining 
autologous cells with a synthetic or biological material which 
provides a mechanically stable 3D environment to culture a 
substitute graft  in vitro suited for implantation. [ 2 ] Therefore, 
tissue engineers and material scientists have been developing 
multitude of scaffold materials, with distinct geometries and 
physicochemical properties, and 3D culture methods. A great 
benefi t of utilizing 3D scaffolds is the opportunity to create con-
structs of clinically relevant sizes and shapes. However, several 
hurdles with respect to cell culture on these scaffolds need to 
be overcome. These include inhomogeneous cell distribution, 
necrotic cores due to nutrient diffusion limitations and lack 
of vascularization, restricted remodelling capacity, and limited 
material-based control of cell fate due to limited accessibility 
of the scaffolds for surface modifi cation or functionalization in 
3D. [ 3 ] These drawbacks to a bigger extent origin from the static 
nature of the scaffolds’ architectures. 
 Recently, bottom-up TE has been introduced to overcome 
these limitations. Bottom-up approaches have the potential 
to construct tissues with defi ned properties including spatial 
and temporal control at cellular level. [ 4 ] Assembling individual 
building blocks allows for the fabrication of large complex 
tissue constructs. Currently, there are several bottom-up 
approaches under investigation from which the state-of-the-
art was reviewed recently. [ 4b , 5 ] A fi rst approach is based on 
scaffold-free cultures where cells are aggregated into 3D tissue 
constructs. [ 5a , 6 ] Baraniak and McDevitt reported that murine 
mesenchymal stromal cells (MSCs) cultured as spheroids in 
suspension without the use of a scaffold as a cell carrier pre-
serve their multilineage potential better than murine MSCs 
cultured as a monolayer. In addition, our group showed that 
the fate of human MSCs (hMSCs) within large aggregates 
is determined by collectively generated actomyosin tension 
depending on the position of the cells within the aggregates. 
These scaffold-free aggregates tend to compact and round up, 
also when one tries to control the aggregate shape by culturing 
in correspondingly shaped wells. This compaction in scaffold-
free approaches is not hindered by a material acting as a spacer, 
resulting in high numbers of cells required to obtain clinically 
relevant sized tissue constructs. 
 A second approach is based on gel-like materials and can over-
come this problem of compaction by allowing the cells to reside 
in an extra cellular matrix (ECM) mimicking environment. [ 7 ] 
The use of hydrogels has shown a high potential in injectable 
systems to reduce  in vivo the invasiveness of surgical procedures 
and to allow  in vitro for controlled assembly achieving complex 
tissues. However, the limitation of hydrogels is their limited 
load bearing capacity which makes them a less suitable material, 
for example, in hard tissue repair. [ 8 ] Moreover, hydrogels only 
allow diffusion of nutrients and gases, soluble factors and waste 
products which limits the size of constructs that can retain cells 
viability. This diffusion limit often results in the cells mainly 
residing on the extremes of the hydrogel where the access to 
oxygen is better, therewith decreasing the homogeneity of the 
cellular distribution. [ 9 ] A third drawback of using hydrogels 
is related to their processing. Most cell-laden hydrogels opted 
for use in TE approaches are processed by crosslinking of cell-
containing precursors with the aid of potentially toxic or dena-
turizing crosslinking agents. This process is known to create 
or represent an unfavorable, chemically reactive (free radicals) 
and toxic microenvironment for the cells also including harmful 
ionizing UV-light and or elevated temperatures. [ 10 ] 
 In contrast to encapsulating cells in hydrogel structures, we 
propose a material-based bottom-up approach in which we let 















the cells self-assemble together with instructive engineered 
solid micro-objects into (shaped) aggregates which then can be 
fused into bigger geometrical units. We hypothesize that our 
method allows for the formation of complex 3D constructs by 
hierarchical assemblies of multiple cell and object types. Cell 
seeding on these individual micro-objects showed to retain cell 
viability and considerably improve cellular distribution com-
pared to conventional 3D scaffolds. Moreover, we also show 
that the modulation of the object’s properties such as their 
shape, size and wettability, in combination with variations of 
cell culture conditions and cell-to-object ratios, tailors the cir-
cularity, branching and compaction of the cell-driven assembly. 
This conveys to the new biofabrication platform proposed here 
an unprecedented degree of freedom in engineering instruc-
tive cell-material interactions, at the same time solving the 
drawbacks of current top-down and bottom-up approaches. 
The micro-objects in our strategy can function as carriers 
for cell delivery or as cell-assembled scaffolds for tissue con-
structs of clinically relevant sizes as shown in  Scheme  1 . Other 
applications could be found in those fi elds working with com-
plex 3D tissues such as stem cell research, cancer research, 
developmental biology, bioartifi cial organs, pharmaceutical 
drug testing or toxicity testing. 
 As in the fi rst instance we want to show the concept of our 
bottom-up approach, the micro-objects were simply fabricated 
by direct lithography from the photocurable epoxy-resin SU-8 
(Microchem) just as a model material. This material is not 
used to replace tissues, but it has a multiple-documented bio-
compatibility and is used in various biomedical microdevices, 
also  in vivo . [ 11 ] We proved however that similar micro-objects 
in principle can be also fabricated from an established thermo-
plastic and photoinitiator-free bio(degradable) polymer such as 
poly-DL-lactic acid by an advanced process based on thermal 
micro- or nanoimprint lithography on a water-soluble sacrifi cal 
layer. The SU-8 objects were released from the wafer on which 
they were fabricated by dissolving a sacrifi cial layer in this 
case from OmniCoat (Microchem) in N-methyl-2-pyrrolidone 
(NMP) (Figure S1 in the Supporting information). To increase 
 Scheme 1.  Schematic representation of bottom-up TE approach with microfabricated solid objects. (A) Micro-objects and (B) cells are cultured in 
(C) arrays of micro-wells to pre-aggregate. (D) Micro-objects directly after seeding. (E, F) Aggregate formation and cell fate (represented by a color 
change) can be infl uenced by the geometrical, mechanical, physical and chemical surface and bulk properties of the objects. (G) After pre-aggregation, 
multiple micro-aggregates can be transferred and pooled into geometrically defi ned wells to fuse into larger sized tissue constructs. (H) Subsequently, 
constructs of different shapes and from various cell types can be combined to form controlled complex tissues. (I) A suspension of micro-objects and 
cells can be applied directly into a defect site where the objects act as a fi ller and as mechanical support, and ideally comprises instructive or inductive 
properties for the cells to grow and differentiate.
















Cells were able to bridge a hole in an object (Figure  1 D) or 
bridge between the extremities of an object (Figure  1 E). A sim-
ilar behavior was found for C2C12 cells. Figure  1 G and H show 
that the iMSCs adhere to the objects and spread over the objects 
surface. At higher magnifi cation (Figure  1 I), it can be clearly 
seen that the cells produce ECM on the material surface, which 
suggests that the cells are highly metabolically active. These 
results show that the observed cell-material interactions are 
promising for further studies on the applicability of the objects 
as potential cell supporting structures. Therefore, the experi-
ments were upscaled to higher number of cells and objects per 
well to study cell-material interactions at larger scale. 
 The number of objects that were assembled into aggregates 
and the compaction of these aggregates were monitored for two 
sizes of cube-shaped objects (medium (M): 40 × 40 × 40 μ m 3 , 
large (L): 80 × 80 × 40  μ m 3 ) (medium cube-shaped objects in 
Figure  1 A) and one size of large cross-shaped objects (90 × 90 × 
40  μ m 3 ; Figure  1 C) at several timepoints. The volume of a cross-
shaped object in these experiments corresponded to the volume 
of a large cube.  Figure  2 shows how fast the cells and objects 
form aggregates. By changing the cell-to-structure ratio, the 
culture conditions, the wettability, and the size and shape of the 
objects, the density of the formed aggregates can be controlled. 
Figure S2 shows the quantifi cation of the aggregation behavior 
the hydrophilicity of the objects, still on the wafer, they were 
treated in an oxygen plasma. To render some objects even more 
hydrophilic, a chemical etch in sulfuric acid was carried out. 
The wettability of the material upon the oxygen and sulfuric 
acid treatment was determined by contact angle measurements 
and protein adsorption tests (fl uorescein-labeled bovine serum 
albumin, BSA) (Table S1 in the Supporting information). 
 After successful release from the wafer, a suspension of 
micro-objects ( Figure  1 A) can be handled like a cell suspension, 
meaning that objects can be centrifuged, counted or even intro-
duced in a fl ow cytometer. Prior to cell culture, the objects were 
washed extensively in deionized (DI-)water and subsequently in 
70% ethanol to remove traces of NMP and to sterilize, respec-
tively. The objects have a defi ned shape which stays intact 
throughout the releasing and sterilization processes (Figure  1 B 
and C). For cell culture experiments, a murine myoblast cell 
line (C2C12), a murine pre-chondrogenic cell line (ATDC5), 
immortalized MSCs (iMSCs), [ 12 ] and hMSCs were used. 
 After combining a relative low number of oxygen-plasma-
treated micro-objects with iMSCs or C2C12 cells on a non-
tissue-culture-treated polystyrene plate, cells were found 
to attach to the SU-8 objects within 24 hours of culture 
(Figure  1 D–F). DAPI/Phalloidin staining shows the nuclei and 
cytoskeletons of multiple iMSCs adhering to individual objects. 
 Figure 1.  (A) Small-sized (20 × 20 × 40  μ m 3 ) micro-objects are successfully released from the wafer by dissolving the OmniCoat sacrifi cial layer after 
fabrication. (B, C) Scanning electron microscopy (SEM) images show that objects with distinct geometries were successfully fabricated and released 
from the substrate wafer. (D–F) When culturing iMSCs on oxygen-treated SU-8 micro-objects, a DAPI (nuclei, blue) and Phalloidin (cytoskeleton, green) 
staining shows that multiple cells adhere to single objects (adapted from bright fi eld image, red), thereby even bridging between the extremities or 
residing in a hole of an object. (G–I) SEM images show that hMSCs adhere to multiple cross-shaped objects. The cells bridge between the objects and 
produce a high amount of ECM-like material.















depending on the cell type was observed in fi ve out of six con-
ditions where iMSCs showed a higher circularity than C2C12 
cells (Figure S3). Only for sulfuric-acid-treated crosses, no sig-
nifi cant difference was found. This difference in aggregation 
behavior between cell types could, just like the relative number 
of objects in an aggregate, be explained by the morphology of 
the cells. Due to the spread morphology of iMSCs compared to 
C2C12 cells, actomyosin forces could be carried out on more 
objects per cell in the case of iMSCs. iMSCs were also found 
to produce a lot of ECM which also could have promoted fast 
aggregation and remodelling. With respect to the infl uence of 
the treatment of the objects, four out of six conditions showed 
a signifi cantly higher circularity for oxygen-plasma-treated 
objects compared to sulfuric-acid-treated objects. This result 
suggests that oxygen plasma treatment not only results in a 
more suitable hydrophilicity for cell adherence but also allows 
cells to a higher extent to spread and adhere to multiple objects 
which induces remodelling and compaction of the aggregate 
possibly by actomyosin forces. Other parameters that could 
have an infl uence on circularity are the shape and size of the 
objects. [ 8 ] With respect to the shape of the structures, cubes 
of the objects and the cells by determining the percentage of the 
total number of objects which was incorporated in an aggregate. 
When the objects were incubated in cell culture medium 
without the presence of cells, no aggregation was observed, even 
after several weeks. The relative number of aggregated objects 
was lower on sulfuric-acid-treated objects than on oxygen-
plasma-treated structures when a low number of cells (500 cells 
per well) was seeded. Furthermore it was found that the rela-
tive number of aggregated objects is lower for C2C12 cells com-
pared to iMSCs. iMSCs are known to spread in culture, whereas 
C2C12 cells show a smaller, spindle-like morphology. This dif-
ference in morphology could lead to iMSCs being able to cover 
more object surface area and can therewith also spread over 
multiple objects. 
 Signifi cant differences were also found in the shape of the 
formed aggregates described by the circularity, which is given 
by a function of the perimeter P and the area A of a projec-
tion of the aggregate (Equation S1 in Supporting information). 
A higher aspect ratio (variance in the diameter of the aggre-
gate) or degree of branching of the aggregate results in a lower 
circularity. A signifi cant difference (p < 0.001) in circularity 
 Figure 2.  (A) Two time sequences of iMSCs cultured with cube-shaped objects of different sizes (fi rst row: large = 80 × 80 × 40  μ m 3 ; second row: 
medium = 40 × 40 × 40  μ m 3 ) on a hemispherical layer of 1% agarose are shown. The sum of the objects’ volumes was adjusted to be the same for 
both sequences. It can be seen that the smaller objects show comparatively high compaction within 4 days, resulting in a round aggregate, whereas 
the larger objects inhibit the remodelling of the aggregate, resulting in a compact, but not complete circular aggregate. (B) After 4 days of culturing, a 
low number of cells combined with large micro-objects (80 × 80 × 40  μ m 3 ) on a fl at layer of 1% agarose, a branched open network of cells and objects 
is found. It can be clearly seen that the geometry of the aggregate is very distinct from the aggregates formed on a hemispherical layer of 1% agarose. 
(C) A calcein/etidium homodimer staining shows that most cells are alive (green) after 7 days of culture, just a few (<5%) dead cells (red) are found 
for hMSCs cultured with multiple object types. (D) Hematoxilin and eosin staining confi rms a homogenous cell distribution within aggregates and 
shows bridging of the cells between the aggregates (indicated by arrows).















N controlled geometry, chondrogenic ATDC5 cells and objects 
were pre-aggregated into spherical aggregates in 400  μ m 
diameter microwells (Figure  3 B). After 4 days of pre-aggrega-
tion, the micro-aggregates were fl ushed out of the microwells 
(Figure  3 C, Video S1B) and successfully fused into larger geo-
metric aggregates in millimetre-sized wells (Figure  3 D). After 
10 days of allowing the aggregates to fuse into millimetre-sized 
toroids, these toroids were stacked to form a stable trachea-
shaped tubular structure within 5 days after stacking (Figure  3 E 
and F). 
 Histological analysis of this toroidal tissue construct again 
showed high number of cells homogeneously distributed 
between the objects without indications of necrosis (Figure S11). 
One can imagine that this same approach could be applied for 
the development of vessel-like constructs when using vascular 
endothelial cells or for defect-shaped bone fi llers when using 
osteoblast precursors, among other applications. 
 To overcome the limitations of cell-based or gel-based 
bottom-up approaches with respect to mechanical stability, 
the micro-objects could function as an enforcing material 
introducing more mechanical stability in for example cellular 
aggregates or in hydrogel approaches (Supporting data Table S2 
and S3) [ 14 ] . To show the potential of our objects to be used in an 
injectable system as presented in Scheme  1 , several injectability 
tests were performed. The following conditions were assessed, 
hMSCs with objects in culture medium, cell-object-aggregates 
in culture medium and cell-object-aggregates in an alginate 
solution which was crosslinked directly after extrusion (Sup-
plementary Video S1-S3). The viability of the injected cells was 
assessed qualitatively 6 hours after extrusion through a 18G 
needle by a live/dead staining (Figure S7 E and F). 
 To overcome possible nutrient defi ciency when upscaling 
the size of the assembled tissue constructs towards the sub-cm 
or cm-range, the objects could for example be designed with 
a high asymmetry or high aspect ratio features which could 
sterically limit compaction introducing cavities and channels 
through which medium can be perfused. Another approach is 
to already enable vascularisation in the early stage of culture  in 
vitro by culturing the cells and objects on top of a vascular bed 
as presented by Sekine et al. [ 15 ] 
 In summary, this study showed how shape, size and wetta-
bility of engineered micro-objects can play an important role 
when cells are allowed to assemble with these objects. A major 
difference between our approach and cell-only or hydrogel-
based bottom-up approaches can be found in the role of the 
cells in assembling macro-sized tissue constructs. [ 6c  , 7a , 13 ,  16 ] The 
approach presented here allows the cells to bind to a substrate 
material allowing cell-cell contact which could be benefi cial for 
certain cell-types and applications. Our approach shows how 
relatively low number of cells are required to obtain large mm-
sized viable tissue constructs compared to cell-only approaches. 
Moreover, the cells are able to actively assemble and remodel 
these aggregates, whereas in hydrogel based bottom-up TE other 
approaches such as DNA-glue have to be introduced to direct 
mesoscale assemblies. By modulating cell attachment sites on 
the micro-objects, higher control on aggregate parameters such 
as aggregation rate and compactness could be achieved. 
 Further development of the bottom-up approach presented 
in this study will be focused on characterization of cell-material 
were expected to show higher circularity than crosses due to 
their more compact geometry. However, differences were found 
only for sulfuric-acid-treated objects seeded with iMSCs where 
large cubes showed a signifi cantly higher circularity than the 
large cross-shaped objects. Structure size was also expected to 
play a role in the compactness of the aggregate, where large 
micro-objects were expected to result in less circular aggregates 
than smaller ones. Though, for this parameter, no signifi cant 
differences were found in any of the conditions. This could be 
caused by the fact that the size and shape of the objects was 
only altered in 2D, whereas the third dimension (the thickness 
of the SU-8 layer in the fabrication process) stayed constant at 
40  μ m. 
 When a low number of cells is combined with large micro-
objects on a fl at layer of 1% agarose (Figure  2 B), the geometry 
of the aggregate was very distinct from the aggregates formed 
on a hemispherical layer of 1% agarose (Figure  2 A). This sug-
gests that the compactness and circularity of the aggregates is 
not solely cell-guided, but can also be modulated by the cul-
ture conditions (Figure S4A–D). Other potential approaches to 
control the density and complexity of the aggregates could for 
example be the design of objects having a high aspect ratio or 
asymmetry, which could inhibit the compaction sterically, or by 
partial functionalizion of the objects to create amphiphilic ele-
ments or to introduce a so-called ‘DNA glue’ for directing the 
mesoscale assembly. [ 13 ] 
 To investigate whether these aggregates can be monitored 
with respect to cell viability, morphology and tissue growth, 
and to increase the clinical relevance, further experiments were 
carried out using oxygen-plasma-treated objects combined 
with hMSCs. Life/dead staining showed a high cell viability 
(>95%) after 4 days (Figure  2 C) of culture which was confi rmed 
by fl ow cytometry on various shapes of SU-8 objects (Figure 
S5). It was also found that the cells distribute homogeneously 
throughout the aggregate and can fuse several small aggregates 
into a larger sized aggregate (Figure  2 D and S6). The viability of 
large aggregates of objects and cells (initially 10,000 objects and 
50,000 hMSCs) and of aggregates consisting of hMSCs only 
was assessed after 11 days of culture and compared (Figure S7). 
 The positive results on cell proliferation found by DNA 
quantifi cation (Figure S8) and the high cell viability shown in 
Figure  2 C, S5 and S7, make the micro-objects promising can-
didates as 3D cell carriers for upscaling expansion cultures. 
Furthermore, the objects have large potential as fi ller material 
since the volume of the obtained tissue constructs showed to 
be much larger compared to cell-only cultures without micro-
objects (Figure S9). 
 To further show that the cells continuously remodel the 
aggregates, three spherical aggregates were brought into one 
well after 7 days of culture. The aggregates clearly merged 
into one larger-sized aggregate within 4 days ( Figure  3 A) as 
already found by histological analysis (Figure  2 D). To study 
migration of cells from one aggregate to another after fusion, 
cells were pre-stained with fl uorescent dyes (Di-I and Di-O). 
The fl uorescently labeled cells were seeded separately with the 
micro-objects to form red or green stained aggregates. Cells did 
not only bridge the aggregates, but migrated from one aggre-
gate to another upon fusion (Figure S10A and B). As a proof 
of concept for engineered larger-sized tissue constructs with 















interactions in combination with micro-objects fabricated from 
biocompatible, implantable materials such as polylactide, pol-
ytrimethylene carbonate or copolymers of polyethylene oxide 
terephthalate and polybutylene terephthalate. Subsequently, a 
major step towards the design of a system in which cell fate and 
tissue shape as well as tissue complexity can be controlled will 
be the investigation of the infl uence of – among others – object 
size, shape, stiffness and surface chemistry or topography on 
cellular phenotype. 
 Ultimately, this approach could not only be used as a tool to 
engineer complex 3D tissues of clinically relevant size, but it 
could also fi nd its application in the clinic for example as inject-
able system, [ 8 ] or in the pharmaceutical industry as a 3D model 
to study tissue pathology and discover potentially new drugs. 
 Experimental Section 
 Micro-Object Fabrication: The OmniCoat sacrifi cial layer was spin-
coated on a 4” silicon wafer followed by a 44 ± 2  μ m layer of SU-8. 
Subsequently, the bilayered fi lm was soft-baked using a programmed 
hotplate (50 °C for 10 min, 65 °C for 10 min, 95 °C for 20 min, cooling 
down back to 25 °C). The micro-objects were obtained by exposing 
the photoresist (soft contact mode 30  μ m, 24 s, Hg, 12 mW cm −2 , 
EVG 620 mask aligner, EV Group, Austria). To harden the photoresist, 
a post exposure bake was performed using a programmed 
hotplate (50 °C for 5 min, 65 °C for 5 min, 80 °C for 10 min, slow 
cool down to 25 °C). The unexposed photoresist was removed by 
spray development for 6 min (Resist Edgebead Remover 600, RER 
600, MicroChem). To increase the hydrophilicity of the structures, 
they were treated in an oxygen plasma (50% O 2 ) for 3 min at 600 W 
(TePla 300E plasma processor). The micro-objects were released from 
the wafer by dissolving the sacrifi cial layer with N-methyl-2-pyrrolidone 
(NMP). To render in some cases the objects even more hydrophilic, 
a chemical etch in 95% sulfuric acid was carried out at 80 °C for 
10 s. The hydrophilicity of the material upon the oxygen plasma and 
sulfuric acid treatment was determined by performing contact angle 
measurements and protein adsorption tests (fl uorescein-labeled BSA, 
Sigma). Prior to cell culture experiments, the objects were sterilized by 
immersion in 70% ethanol twice for 30 min, followed by washing three 
times in phosphate-buffered saline (PBS). Subsequently, the objects 
were incubated in 10% fetal bovine serum (FBS, Lonza) containing 
culture media for at least 24 h. 
 Figure 3.  (A) After 7 days of aggregation on a hemispherical layer of 1% agarose, three aggregates were brought into close vicinity into one well. Within 
4 days, the aggregates fused due to cells bridging and migrating from one aggregate to another. (B) Cells and objects are pre-aggregated in agarose 
microwells with a diameter of 400  μ m. (C) After 4 days, stable and compact aggregates can be fl ushed out of the wells and transferred to larger-sized, 
geometrically shaped agarose wells. (D) Toroidal tissue constructs are formed within 4 days of culture which can subsequently be stacked on a needle 
to form (E, F) stable tubular structures within another 4 days.















N  Cell Culture: hMSC isolation and expansion was performed as 
previously described on human bone marrow aspirates obtained 
from donors after written informed consent [ 17 ] iMSCs represent an 
immortalized clone retrieved after transducing hMSCs with the gene for 
the catalytic subunit of human telomerase (hTERT) (iMSCs, courtesy 
of Ola Myklebost, University of Oslo, Norway). hMSCs and iMSCs 
were cultured in a monolayer in proliferation medium consisting of 
alpha minimum essential medium ( α -MEM, Gibco) supplemented 
with L-glutamine (2 m m , Gibco), penicillin (100 U ml −1 , Gibco) and 
streptomycin (100 mg ml −1 , Gibco), FBS (10% (w v −1 ), Lonza), basic 
fi broblast growth factor (1 ng ml −1 , bFGF, Instruchemie) and ascorbic 
acid (0.2 mM, Sigma). C2C12 and ADTC5 cells were cultured in a 
monolayer in Dulbecco’s Modifi ed Eagle medium (DMEM, Gibco) 
supplemented with penicillin (100 U ml −1 , Gibco) and streptomycin 
(100 mg ml −1 , Gibco), and 10% FBS ((w v −1 ), Lonza) for C2C12 cells and 
5% FBS for ADTC5 cells. Standard culturing conditions were 37 °C with 
a humidifi ed 5% CO 2 /95% air atmosphere. Media were renewed every 
second (ATDC5) or third day (all other cell types). Cells were detached 
using trypsin (0.25% (w v −1 )) in ethylenediaminetetra-acetic acid (EDTA) 
solution when a confl uency of 70–80% was reached. 
 Cell Seeding on the Micro-Objects : The concentration of micro-objects 
in medium after incubation was determined by counting the number 
of structures in 10  μ L. Subsequently, a certain number of objects was 
added to the wells of the culture plates. Additionally, a specifi c number 
of cells was added within the same well. Mixing was applied by pipetting 
up and down shortly while adding medium up to the standard volume 
for that specifi c well. 
 Quantifi cation of Aggregation Behavior : The number of structures 
incorporated within an aggregate was determined by counting the total 
number of structures in the well directly after seeding manually by image 
analysis. After 4 days of culture, the number of structures that was not 
incorporated within the aggregate was counted manually by image 
analysis. Circularity was calculated as a function of the perimeter (P) and 
area (A) of the aggregate measured by image analysis using the function 
‘measure’ in ImageJ. The outline of the aggregate, corresponding to the 
perimeter, was drawn manually.




 Viability Staining : To determine cell viability throughout the 
aggregates, a live/dead staining was performed. After washing the 
aggregates twice with PBS, they were incubated for 30 min with a 6  μ M 
ethidium homodimer (red fl uorescent)/1  μ M calcein (green fl uorescent) 
mixture in PBS solution (LIVE/DEAD viability/cytotoxicity kit, Invitrogen/
Molecular Probes) at room temperature (RT). Prior to imaging, 
aggregates were washed with PBS three times. Images were taken with 
a fl uorescence microscope (Nikon Eclipse E600 and Nikon DS-Fi1c 
camera) using a Nikon Texas Red/FITC fi lter set. 
 Histology: Samples were dehydrated in increasing concentrations of 
ethanol (50, 60, 70, 80, 90, 96 and 100% (v v −1 )) for 30 min per step. Prior 
to embedding the samples into a two-component glycol methacrylate 
(GMA) (Merck) acrylic resin, the 100% ethanol was exchanged with 50% 
(v v −1 ) GMA-component A in ethanol and incubated over night (o/n) 
at 4 °C. Additionally, the samples were immersed in 100% GMA-A for 
8 h at 4 °C. The samples were transferred to a Tefl on ®  mold and the 
two-component GMA was added and allowed to polymerize for 48 h. 
Sections of 10  μ m thickness were obtained by cutting with a microtome 
(Microm HM355S, Thermo Scientifi c). Prior to staining, the sections 
were rehydrated in DI-water for 10 min. For the hematoxilin and eosin 
staining, Gill’s hematoxylin (Sigma-Aldrich) was applied for 30 min. 
After rinsing 3 min with tab water and additionally 3 min in DI-water, 
samples were counterstained with eosin for 6 min and dehydrated in 
100% ethanol. The samples were dehydrated with ethanol, coverslips 
were mounted and imaging was carried out using a Nikon Eclipse E600 
with a Nikon DS-Fi1c camera. 
 Preparation and Filling of Microwell Arrays: Patterned chips from 
polydimethylsiloxane (PDMS) were placed in a 6-well plate (NUNC). 
A heated agarose solution (3% (w v −1 ), UltraPure agarose, Invitrogen) 
was casted on each PDMS chip. The agarose was allowed to solidify at 
4 °C. Subsequently, the molds were removed from the obtained agarose 
chips. Cylindrical pieces were punched out of the agarose chips and 
placed in 12-well plates. To fi ll the cylindrical microwells, objects were 
added in small amounts until all the wells were completely covered 
with structures. Additionally, a certain amount of cells was added, and 
a short centrifugation after mixing promoted the cells and objects to 
settle in the microwells. 
 Statistical Analysis : All results were expressed as mean value and 
standard deviation (error bars). Statistical signifi cance was tested 
by one-way analysis of variance (ANOVA) and Tukey’s Multiple 
Comparison Test was carried out as post-hoc comparison using SPSS 
Statistics software (IBM). Statistical signifi cance is indicated by *, ** 
or *** corresponding to p < 0.05, p < 0.01 and p < 0.001, respectively. 
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 Supporting Information is available from the Wiley Online Library or 
from the author. 
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